“Inflammatory bowel disease is driven by an excessive immune response in the gut wall. This review summarises important new developments in understanding this immune response and the downstream mechanisms of intestinal injury, alongside their potential role in opening up new avenues of treatment…
Understanding the immunology of inflammatory bowel disease continues to underpin the vast majority of new therapies and identifies new targets.
Novel approaches, such as exploiting the antiinflammatory role of cannabinoid receptors, may also prove productive in the future.”